↓ Skip to main content

Vitamin D to prevent acute lung injury following oesophagectomy (VINDALOO): study protocol for a randomised placebo controlled trial

Overview of attention for article published in Trials, April 2013
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
74 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Vitamin D to prevent acute lung injury following oesophagectomy (VINDALOO): study protocol for a randomised placebo controlled trial
Published in
Trials, April 2013
DOI 10.1186/1745-6215-14-100
Pubmed ID
Authors

Dhruv Parekh, Rachel C A Dancer, Sian Lax, Mark S Cooper, Adrian R Martineau, William D Fraser, Olga Tucker, Derek Alderson, Gavin D Perkins, Fang Gao-Smith, David R Thickett

Abstract

BACKGROUND: Acute lung injury occurs in approximately 25% to 30% of subjects undergoing oesophagectomy. Experimental studies suggest that treatment with vitamin D may prevent the development of acute lung injury by decreasing inflammatory cytokine release, enhancing lung epithelial repair and protecting alveolar capillary barrier function. METHODS: The 'Vitamin D to prevent lung injury following oesophagectomy trial' is a multi-centre, randomised, double-blind, placebo-controlled trial. The aim of the trial is to determine in patients undergoing elective transthoracic oesophagectomy, if pre-treatment with a single oral dose of vitamin D3 (300,000 IU (7.5 mg) cholecalciferol in oily solution administered seven days pre-operatively) compared to placebo affects biomarkers of early acute lung injury and other clinical outcomes. The primary outcome will be change in extravascular lung water index measured by PiCCO(R) transpulmonary thermodilution catheter at the end of the oesophagectomy. The trial secondary outcomes are clinical markers indicative of lung injury: PaO2:FiO2 ratio, oxygenation index; development of acute lung injury to day 28; duration of ventilation and organ failure; survival; safety and tolerability of vitamin D supplementation; plasma indices of endothelial and alveolar epithelial function/injury, plasma inflammatory response and plasma vitamin D status. The study aims to recruit 80 patients from three UK centres. DISCUSSION: This study will ascertain whether vitamin D replacement alters biomarkers of lung damage following oesophagectomy.Trial registration Current Controlled Trials ISRCTN27673620.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 74 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Mexico 1 1%
New Zealand 1 1%
Unknown 72 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 16%
Student > Master 10 14%
Student > Ph. D. Student 8 11%
Student > Bachelor 6 8%
Other 4 5%
Other 17 23%
Unknown 17 23%
Readers by discipline Count As %
Medicine and Dentistry 35 47%
Agricultural and Biological Sciences 5 7%
Biochemistry, Genetics and Molecular Biology 3 4%
Nursing and Health Professions 3 4%
Social Sciences 2 3%
Other 7 9%
Unknown 19 26%